Fengwei Nan

496 total citations
8 papers, 371 citations indexed

About

Fengwei Nan is a scholar working on Molecular Biology, Neurology and Geriatrics and Gerontology. According to data from OpenAlex, Fengwei Nan has authored 8 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Geriatrics and Gerontology. Recurrent topics in Fengwei Nan's work include Ginseng Biological Effects and Applications (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Fengwei Nan is often cited by papers focused on Ginseng Biological Effects and Applications (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Fengwei Nan collaborates with scholars based in China and United States. Fengwei Nan's co-authors include Guibo Sun, Xiangbao Meng, Ping Zhou, Xi Dong, Weijie Xie, Xiaobo Sun, Yu Jiang, Hua Jiang, Wei Chen and Zhangping Yu and has published in prestigious journals such as Frontiers in Pharmacology, Oxidative Medicine and Cellular Longevity and Clinical Nutrition.

In The Last Decade

Fengwei Nan

8 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengwei Nan China 8 156 93 92 53 41 8 371
Dalia M. El-Tanbouly Egypt 14 183 1.2× 67 0.7× 60 0.7× 75 1.4× 24 0.6× 28 499
Mostafa A. Rabie Egypt 12 184 1.2× 48 0.5× 65 0.7× 37 0.7× 22 0.5× 35 451
Kai-Jung Lin Taiwan 9 188 1.2× 50 0.5× 109 1.2× 93 1.8× 46 1.1× 10 496
Rania M. Salama Egypt 13 198 1.3× 62 0.7× 66 0.7× 40 0.8× 37 0.9× 25 492
Ju-Bin Kang South Korea 13 159 1.0× 176 1.9× 78 0.8× 33 0.6× 43 1.0× 40 486
Jianrui Lv China 12 213 1.4× 112 1.2× 67 0.7× 60 1.1× 43 1.0× 30 501
Tianyu Meng China 10 135 0.9× 71 0.8× 58 0.6× 30 0.6× 24 0.6× 15 328
Xiaonan Ma China 9 319 2.0× 86 0.9× 84 0.9× 97 1.8× 41 1.0× 14 510

Countries citing papers authored by Fengwei Nan

Since Specialization
Citations

This map shows the geographic impact of Fengwei Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengwei Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengwei Nan more than expected).

Fields of papers citing papers by Fengwei Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengwei Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengwei Nan. The network helps show where Fengwei Nan may publish in the future.

Co-authorship network of co-authors of Fengwei Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Fengwei Nan. A scholar is included among the top collaborators of Fengwei Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengwei Nan. Fengwei Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, Huanyuan, et al.. (2021). Naofucong Ameliorates High Glucose Induced Hippocampal Neuron Injury Through Suppressing P2X7/NLRP1/Caspase-1 Pathway. Frontiers in Pharmacology. 12. 647116–647116. 24 indexed citations
2.
Dong, Xi, Zhu Feng Yue, Shan Wang, et al.. (2020). Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway. International Immunopharmacology. 88. 106865–106865. 31 indexed citations
3.
Xie, Weijie, Ting Zhu, Ping Zhou, et al.. (2020). Notoginseng leaf triterpenes ameliorates mitochondrial oxidative injury via the NAMPT-SIRT1/2/3 signaling pathways in cerebral ischemic model rats. Journal of Ginseng Research. 47(2). 199–209. 26 indexed citations
4.
Xie, Weijie, Ting Zhu, Ping Zhou, et al.. (2020). Notoginseng Leaf Triterpenes Ameliorates OGD/R-Induced Neuronal Injury via SIRT1/2/3-Foxo3a-MnSOD/PGC-1α Signaling Pathways Mediated by the NAMPT-NAD Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–15. 53 indexed citations
5.
Nan, Fengwei, Guibo Sun, Weijie Xie, et al.. (2019). Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway. Molecular and Cellular Probes. 48. 101469–101469. 23 indexed citations
6.
Xie, Weijie, Xiangbao Meng, Yadong Zhai, et al.. (2019). Antidepressant-like effects of the Guanxin Danshen formula via mediation of the CaMK II-CREB-BDNF signalling pathway in chronic unpredictable mild stress-induced depressive rats. Annals of Translational Medicine. 7(20). 564–564. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026